SlideShare una empresa de Scribd logo
1 de 31
Fingerprinting of Herbal Drugs using
 Advanced Bioanalytical Techniques


           Dr. Bhaswat S. Chakraborty



10/12/12                                1
10/12/12   2
Herbal Drugs as Traditional Medicine
    “…the medicine that refers to health practices,
    approaches, knowledge and beliefs
    incorporating plant, animal and mineral based
    medicines, spiritual therapies, manual
    techniques and exercises, applied singularly or
    in combination to treat, diagnose and prevent
    illnesses or maintain well-being …”
                                             WHO

10/12/12                                              3
Some Indian Medicinal Plants




10/12/12                              4
Use of Traditional Medicine
• Worldwide 40-70% people use traditional medicine (of herbal,
  animal or mineral origin)
      – Exclusively, alternately or terminally
• The quality of herbal medicines is often poor
      – Production of herbals is not controlled or regulated
• Herbal medicines usually contain a range of pharmacologically
  active compounds
      – Often not known which of these constituents produces the therapeutic
        effect.
      – Testing for efficacy is more complex than with synthetic drugs
• Complex safety issues
      – Toxicity of natural herbal constituents
      – Presence of contaminants or adulterants
      – Herb-herb or herb-prescription drug interactions


10/12/12                                                                       5
Renewed Interest in Herbal Medicine
•   The effectiveness of plant medicines.
•   The preference of consumers for natural therapies, a greater interest in
    alternative medicines and a commonly held erroneous belief that herbal
    products are superior to manufactured products.
•    A dissatisfaction with the results from synthetic drugs and the belief that
    herbal medicines might be effective in the treatment of certain diseases
    where conventional therapies and medicines have proven to be inadequate.
•   The high cost and side effects of most modern drugs.
•   Improvements in the quality, efficacy, and safety of herbal medicines with
    the development of science and technology.
•   Patients’ belief that their physicians have not properly identified the
    problem; hence they feel that herbal remedies are another option.
•   A movement towards self-medication

10/12/12                                                                       6
But the Problem is
• Herbal drugs are usually mixtures of many constituents.
• The active principle(s) is (are), in most cases unknown.
• Selective analytical methods or reference compounds may not be
  available commercially.
• Plant materials are chemically and naturally variable.
• The same species varies in various drug contents depending on
  locality, cultivation process, etc.
• The source and quality of the raw material are variable.
• The methods of harvesting, drying, storage, transportation, and
  processing (for example, mode of extraction and polarity of the
  extracting solvent, instability of constituents, etc.) have an effect.

10/12/12                                                                   7
QC of Herbal Drugs
•   Identity
•   Purity
•   Content or assay – very challenging for herbal drugs
•   Parameters for Quality Control of Herbal Drugs
      –    Microscopy
      –    Foreign matter determination
      –    Determination of ash
      –    Determination of heavy metals
      –    Determination of Microbial Contaminants and Aflatoxins
      –    Determination of Pesticide Residues
      –    Determination of Radioactive Contamination
      –    Analytical method and its validation

10/12/12                                                            8
Why QC Herbal Drugs?
•   Accurate identity and specifications
•   Content uniformity
•   Reduced batch to batch variability
•   Efficacy related to quality
•   Safety
      – Some sub-species can be very toxic
• Raw drug and dosage form stability
• Control of shelf life decreasing contaminations
10/12/12                                        9
Sample Preparation for
     Chromatographic Fingerprinting
• Follows the same priciples as those for any HPLC (or
  other chromatographic) analysis
• Herbs may require very specific additional steps prior
  to chromatographic analysis
      – Grinding and pulverizing
      – Extraction
           •   Organic solvent
           •   Organic solvent free
           •   Super-critical fluid
           •   Co-solvent super-critical
      – Hydro-distillation of essential oils
10/12/12                                               10
Instead of chemical solvent, compressed CO2 is used. It is a fine
extracting solvent and doesn’t contaminate the herb, environment
or our body.




10/12/12                                                        11
LC-MS-MS




10/12/12              12
MS vs. MS/MS

                                      Mass
HPLC         Inlet         Ionize                       Detect
                                     Analyze


                               MS
              Separation                    Identification


                            Mass                      Mass
 Inlet       Ionize                  Fragment                    Detect
                           Analyze                   Analyze

                             MS1     Collision         MS2
                                       Cell

                           MS/MS
  10/12/12                                                         13
Chromatographic Fingerprinting of Herbs
• These are chromatograms representing characteristics of the
  herbs
      – Identity, consistency and authenticity of samples
• Hyphenated techniques (GC/MS, LC/MS and CE/MS) show
  greatly improved performances
      – retention time shift, selectivity, chromatographic separation abilities
        and measurement precision
• Chromatographic fingerprinting is a highly accurate,
  meaningful quality control method of herbal medicines
• Since it is usually difficult to distinguish herbal drugs by
  different manufactures visually, principal components analysis
  (PCA) is used.
10/12/12                                                                          14
Curcumin
                   + 1 0 1 m fr m a p 1( 1 4 9 P S IV ( 1_ U C M ) o Q .w ( ub S r y, C n o e
                    Q : .0 7 in o S mle 0 0 0 _ O IT EQ ) C R U IN f 1 iff T r o pa ) e tr id d                                                                                            Mx 2 e c s
                                                                                                                                                                                            a . .3 7 p .

                               23
                                2 .1
                   2 e
                    .3 7
                   2 e
                    .2 7

                   2 e
                    .1 7

                   2 e
                    .0 7

                   1 e
                    .9 7

                   1 e
                    .8 7

                   1 e
                    .7 7

                   1 e
                    .6 7

                   1 e
                    .5 7    22
                             1 .0

                   1 e
                    .4 7
Intensity, cps




                   1 e
                    .3 7     27
                             1 .0

                   1 e
                    .2 7

                   1 e
                    .1 7

                   1 e
                    .0 7                                                                                    31
                                                                                                             9 .4
                                                         29
                                                          7 .2
                   9 e
                    .0 6
                                        24
                                         4 .9
                   8 e
                    .0 6
                                                                  26
                                                                   9 .2
                   7 e
                    .0 6                                                                                                                     44
                                                                                                                                              6 .5
                                                                                                  39
                                                                                                  6 .1
                   6 e
                    .0 6                       26
                                                5 .3                             34
                                                                                  3 .6
                                    22
                                     3 .4
                           22
                            0 .1
                   5 e
                    .0 6               29
                                        4 .2    21
                                                 6 .1             35
                                                                   0 .2
                            23
                             1 .9                       26 30
                                                         6 .2 0 .5                        32
                                                                                           5 .3                48 43
                                                                                                                0 .5 1 .4
                   4 e
                    .0 6                                                  3 4 1 .0
                                                                           1 .33 9                                                                        42
                                                                                                                                                           9 .6
                             2 .1 2 0 2 5
                            21     3 .1 3 .1           25 21
                                                        7 .0 9 .1                            38
                                                                                              5 .3          38
                                                                                                            8 .4
                                                                                                                    41 48
                                                                                                                     1 .4 2 .5               45
                                                                                                                                              6 .4
                   3 e
                    .0 6                        21
                                                5 .4                                                 33
                                                                                                     6 .2                        45
                                                                                                                                  5 .3
                                                                    33
                                                                     0 .2            34
                                                                                      4 .3                          40
                                                                                                                     0 .6
                                                          22
                                                           7 .3              36
                                                                              2 .8                   37
                                                                                                      7 .2                   42
                                                                                                                             3 .4             48 44
                                                                                                                                               5 .4 7 .6            55 53
                                                                                                                                                                     2 .0 3 .0 5 0
                                                                                                                                                                                5 .8
                   2 e 27 25 28
                    .0 6 0 .1 1 .3 3 .9          23
                                                  6 .2
                                                                                          35 39
                                                                                           6 .2 7 .1
                                                                                                                                                            57
                                                                                                                                                             0 .3                           58
                                                                                                                                                                                             7 .9
                                                                                     32
                                                                                      4 .4                            45
                                                                                                                      2 .3                                          56 51
                                                                                                                                                                     1 .9 4 .0         55
                                                                                                                                                                                        6 .3
                                                                                                    34
                                                                                                     7 .4                            47
                                                                                                                                      4 .3     40
                                                                                                                                               7 .5 4 8                       54
                                                                                                                                                                               4 .9               52
                                                                                                                                                                                                   9 .7
                   1 e
                    .0 6                                                                                                                             7 .9
                                                                                                                             43
                                                                                                                              2 .4                                                          57
                                                                                                                                                                                             8 .2

                       20
                        0      20
                                2      20
                                        4        20
                                                 6        20
                                                          8         30
                                                                     0      30
                                                                             2       30
                                                                                      4       30
                                                                                               6       30
                                                                                                        8       40
                                                                                                                 0   40
                                                                                                                     2          40
                                                                                                                                 4           40
                                                                                                                                             6       40
                                                                                                                                                      8      50
                                                                                                                                                              0       50
                                                                                                                                                                       2    50
                                                                                                                                                                             4        50
                                                                                                                                                                                       6     50
                                                                                                                                                                                              8      60
                                                                                                                                                                                                     0
                                                                                                              m ,a u
                                                                                                               /z m


                 10/12/12                                                                                                                                                                             15
Total Ion Current of Parent Ion




          Parent Ion of Curcumin
HPLC Fingerprint of Ashwagandha




10/12/12          Dr. Quazi et al (downloaded), CSIR   17
Glycowithanolides and Withanolides
          from Ashwagandha




10/12/12               Dr. Quazi et al (downloaded), CSIR   18
LC-MS Fingerprint of Ashwagandha




10/12/12              Dr. Quazi et al (downloaded), CSIR   19
Fingerprint of Formulations




10/12/12                                                        20
                           Dr. Quazi et al (downloaded), CSIR
Total Ion Chromatogram of Ginseng Sample




10/12/12                              21
10/12/12
Chromatograms of Different Batches of
    Ginseng in Shenmai injection




22
Similarity of Fingerprints
• Equivalence of herbal drugs of different sources –
  “Phytoequivalence”
      – Very good, reproducible and accurate chromatograms are needed
• For good comparison, correction of retention time shifts of the
  component drugs is necessary
• So many components from so many sources
      – Visual comparison is extremely difficult
      – May even be misleading
• Chemometric techniques,e.g., Principal Component
  Analysis (PCA) are used to confirm similarity or dis-
  similarity
10/12/12                                                                23
Phytoequivalence




TIC of essential oils of Cortex
cinnamomi from four different
sources




 10/12/12                         Liang et al (2004), J Chromat B, 812, 53-70   24
Correction for RT Shift



               Chromatograms of Ginko biloba
               samples by two different HPLC
               instruments




10/12/12   Liang et al (2004), J Chromat B, 812, 53-70   25
Principal Component Analysis
           HPLC UV of G. biloba extracts from 17 different sources




10/12/12                             Liang et al (2004), J Chromat B, 812, 53-70   26
Principal Component Analysis
           HPLC UV of G. biloba extracts from 17 different sources




                                                       Different fingerprint
                                                       from those below




10/12/12                             Liang et al (2004), J Chromat B, 812, 53-70   27
Principal Component Analysis
           HPLC UV of G. biloba extracts from 17 different sources




10/12/12                             Liang et al (2004), J Chromat B, 812, 53-70   28
On-Line Chemometric Comparison
     HPLC-MS TIC of Schisandra extracts by 6 different methods




                                                 Liang et al (2004),
10/12/12
                                            J Chromat B, 812, 53-70    29
DNA Microarray of Herbal Drugs




10/12/12       Wang M et al (2005), Phytotherap Res 19, 173-182   30
Thank You



10/12/12               31

Más contenido relacionado

La actualidad más candente

La actualidad más candente (20)

DNA FINGERPRINTING TECHNIQUE FOR IDENTIFICATION OF DRUGS OF NATURAL ORIGIN AN...
DNA FINGERPRINTING TECHNIQUE FOR IDENTIFICATION OF DRUGS OF NATURAL ORIGIN AN...DNA FINGERPRINTING TECHNIQUE FOR IDENTIFICATION OF DRUGS OF NATURAL ORIGIN AN...
DNA FINGERPRINTING TECHNIQUE FOR IDENTIFICATION OF DRUGS OF NATURAL ORIGIN AN...
 
Dna fingerprinting of herbal drugs
Dna fingerprinting of herbal drugsDna fingerprinting of herbal drugs
Dna fingerprinting of herbal drugs
 
MONOGRAPHS OF HERBAL DRUGS
MONOGRAPHS OF HERBAL DRUGS MONOGRAPHS OF HERBAL DRUGS
MONOGRAPHS OF HERBAL DRUGS
 
Safety Monitoring of Natural Medicine
Safety Monitoring of Natural MedicineSafety Monitoring of Natural Medicine
Safety Monitoring of Natural Medicine
 
1)spontanious reporting schemes for biodrug adverse reactions
1)spontanious reporting schemes for biodrug adverse reactions1)spontanious reporting schemes for biodrug adverse reactions
1)spontanious reporting schemes for biodrug adverse reactions
 
Stability Testing of Phytopharmaceuticals
Stability Testing of PhytopharmaceuticalsStability Testing of Phytopharmaceuticals
Stability Testing of Phytopharmaceuticals
 
Regulatory requirement for setting herbal drug industry
Regulatory requirement for setting herbal drug industryRegulatory requirement for setting herbal drug industry
Regulatory requirement for setting herbal drug industry
 
quality control methods for herbal drugs
quality control methods for herbal drugsquality control methods for herbal drugs
quality control methods for herbal drugs
 
monographs of herbal drugs I.P, U.S.P, A.H.P, B.P..pptx
monographs of herbal drugs I.P, U.S.P, A.H.P, B.P..pptxmonographs of herbal drugs I.P, U.S.P, A.H.P, B.P..pptx
monographs of herbal drugs I.P, U.S.P, A.H.P, B.P..pptx
 
Standardization of Herbal Drugs
Standardization of Herbal DrugsStandardization of Herbal Drugs
Standardization of Herbal Drugs
 
Adulteration and Deterioration- Durgashree Diwakar
Adulteration and Deterioration- Durgashree DiwakarAdulteration and Deterioration- Durgashree Diwakar
Adulteration and Deterioration- Durgashree Diwakar
 
Effects of herbal drugs on clinical laboratories testing
Effects of herbal drugs on clinical laboratories testing Effects of herbal drugs on clinical laboratories testing
Effects of herbal drugs on clinical laboratories testing
 
EFFICACY OF HERBAL PRODUCTS
EFFICACY OF HERBAL PRODUCTS EFFICACY OF HERBAL PRODUCTS
EFFICACY OF HERBAL PRODUCTS
 
Role of chemical & biological marker.pptx
Role of chemical & biological marker.pptxRole of chemical & biological marker.pptx
Role of chemical & biological marker.pptx
 
Monographs of Herbal Drugs Study in British Herbal Pharmacopoeia and American...
Monographs of Herbal Drugs Study in British Herbal Pharmacopoeia and American...Monographs of Herbal Drugs Study in British Herbal Pharmacopoeia and American...
Monographs of Herbal Drugs Study in British Herbal Pharmacopoeia and American...
 
Herbal drug regulations
Herbal drug regulationsHerbal drug regulations
Herbal drug regulations
 
Analytical evaluation of herbal drugs
Analytical evaluation of herbal drugsAnalytical evaluation of herbal drugs
Analytical evaluation of herbal drugs
 
WHO Guidelines for QC of Herbal Drugs
WHO Guidelines for QC of Herbal DrugsWHO Guidelines for QC of Herbal Drugs
WHO Guidelines for QC of Herbal Drugs
 
Stability testing of herbal natural products and its
Stability testing of herbal natural products and itsStability testing of herbal natural products and its
Stability testing of herbal natural products and its
 
stability testing
stability testingstability testing
stability testing
 

Destacado

Standardisation of herbal drug
Standardisation of herbal drugStandardisation of herbal drug
Standardisation of herbal drug
Vineet Gupta
 
Standardisation of herbal drg
Standardisation of herbal drgStandardisation of herbal drg
Standardisation of herbal drg
Priyanka Yadav
 
Herbal drugs and fingerprints
Herbal drugs and fingerprintsHerbal drugs and fingerprints
Herbal drugs and fingerprints
Springer
 
Tandem Mass spectrometry
Tandem Mass spectrometryTandem Mass spectrometry
Tandem Mass spectrometry
Asif Javed
 
Standardization of herbal drug Ppt
Standardization  of herbal drug PptStandardization  of herbal drug Ppt
Standardization of herbal drug Ppt
inder makhija
 
Antidepressants powerpoint
Antidepressants powerpointAntidepressants powerpoint
Antidepressants powerpoint
Allegra Lange
 

Destacado (20)

Standardisation of herbal drug
Standardisation of herbal drugStandardisation of herbal drug
Standardisation of herbal drug
 
Standardisation of herbal drg
Standardisation of herbal drgStandardisation of herbal drg
Standardisation of herbal drg
 
Herbal drugs and fingerprints
Herbal drugs and fingerprintsHerbal drugs and fingerprints
Herbal drugs and fingerprints
 
quality control of herbal drugs
quality control of herbal drugsquality control of herbal drugs
quality control of herbal drugs
 
pde5i adulteration of herbal supplements
pde5i adulteration of herbal supplementspde5i adulteration of herbal supplements
pde5i adulteration of herbal supplements
 
Herbal supplements revised
Herbal supplements revisedHerbal supplements revised
Herbal supplements revised
 
Herbs for Anxiety
Herbs for AnxietyHerbs for Anxiety
Herbs for Anxiety
 
Dr.r.k.dhuria hydroponics aks, new delhi
Dr.r.k.dhuria hydroponics aks, new delhiDr.r.k.dhuria hydroponics aks, new delhi
Dr.r.k.dhuria hydroponics aks, new delhi
 
Herbalism benifits of MedicinalPlants By Allah Dad Khan
Herbalism benifits of MedicinalPlants By Allah Dad Khan Herbalism benifits of MedicinalPlants By Allah Dad Khan
Herbalism benifits of MedicinalPlants By Allah Dad Khan
 
Role of biomarkers and dna fingerprinting in herbal drug standardisation
Role of biomarkers and dna fingerprinting in herbal drug standardisationRole of biomarkers and dna fingerprinting in herbal drug standardisation
Role of biomarkers and dna fingerprinting in herbal drug standardisation
 
Potentially hazardous contaminants and residues in herbal medicines and its p...
Potentially hazardous contaminants and residues in herbal medicines and its p...Potentially hazardous contaminants and residues in herbal medicines and its p...
Potentially hazardous contaminants and residues in herbal medicines and its p...
 
Tandem Mass spectrometry
Tandem Mass spectrometryTandem Mass spectrometry
Tandem Mass spectrometry
 
Herbals in pharma industry
Herbals in pharma industryHerbals in pharma industry
Herbals in pharma industry
 
Quality control of herbal drug
Quality control of herbal drugQuality control of herbal drug
Quality control of herbal drug
 
Physical and biological method of drug evaluation by Dr.U.Srinivasa
Physical and biological method of drug evaluation by Dr.U.SrinivasaPhysical and biological method of drug evaluation by Dr.U.Srinivasa
Physical and biological method of drug evaluation by Dr.U.Srinivasa
 
Herbal drug formulation and evaluation
Herbal drug formulation and evaluationHerbal drug formulation and evaluation
Herbal drug formulation and evaluation
 
Drug degradation
Drug degradationDrug degradation
Drug degradation
 
Standardization of herbal drug Ppt
Standardization  of herbal drug PptStandardization  of herbal drug Ppt
Standardization of herbal drug Ppt
 
Mass spectrometry
Mass spectrometryMass spectrometry
Mass spectrometry
 
Antidepressants powerpoint
Antidepressants powerpointAntidepressants powerpoint
Antidepressants powerpoint
 

Similar a Fingerprinting of herbal drugs using advanced bioanalytical techniques

NANOMEDICINE PPT.pptx
NANOMEDICINE PPT.pptxNANOMEDICINE PPT.pptx
NANOMEDICINE PPT.pptx
BHARATHIAR UNIVERSITY
 
2016 AEHS Statistics Sediment Forensic Presentation CHERRY
2016 AEHS Statistics Sediment Forensic Presentation CHERRY2016 AEHS Statistics Sediment Forensic Presentation CHERRY
2016 AEHS Statistics Sediment Forensic Presentation CHERRY
Eric Cherry
 
Preformulation testing of solid dosage forms
Preformulation testing of solid dosage formsPreformulation testing of solid dosage forms
Preformulation testing of solid dosage forms
Sunil Boreddy Rx
 
BRIN research poster
BRIN research posterBRIN research poster
BRIN research poster
Cory Noss
 

Similar a Fingerprinting of herbal drugs using advanced bioanalytical techniques (20)

Crystallography
CrystallographyCrystallography
Crystallography
 
Natural products in drug discovery
Natural products in drug discoveryNatural products in drug discovery
Natural products in drug discovery
 
Nanoparticles
NanoparticlesNanoparticles
Nanoparticles
 
Nanoparticles and liposomes ppt
Nanoparticles and liposomes pptNanoparticles and liposomes ppt
Nanoparticles and liposomes ppt
 
psdarticle2014
psdarticle2014psdarticle2014
psdarticle2014
 
Madhavi mutha
Madhavi muthaMadhavi mutha
Madhavi mutha
 
NANOMEDICINE PPT.pptx
NANOMEDICINE PPT.pptxNANOMEDICINE PPT.pptx
NANOMEDICINE PPT.pptx
 
Analytical Method Development and validation of UV-Visible spectroscopy
Analytical Method Development and validation of UV-Visible spectroscopyAnalytical Method Development and validation of UV-Visible spectroscopy
Analytical Method Development and validation of UV-Visible spectroscopy
 
1 introduciton to analytical chemistry1
1 introduciton to analytical chemistry11 introduciton to analytical chemistry1
1 introduciton to analytical chemistry1
 
Ceo2 nps
Ceo2 npsCeo2 nps
Ceo2 nps
 
Formulation and evaluation of effect of different stabilizer at nanosuspensio...
Formulation and evaluation of effect of different stabilizer at nanosuspensio...Formulation and evaluation of effect of different stabilizer at nanosuspensio...
Formulation and evaluation of effect of different stabilizer at nanosuspensio...
 
Formulation and evaluation of effect of different stabilizer at nanosuspensio...
Formulation and evaluation of effect of different stabilizer at nanosuspensio...Formulation and evaluation of effect of different stabilizer at nanosuspensio...
Formulation and evaluation of effect of different stabilizer at nanosuspensio...
 
2016 AEHS Statistics Sediment Forensic Presentation CHERRY
2016 AEHS Statistics Sediment Forensic Presentation CHERRY2016 AEHS Statistics Sediment Forensic Presentation CHERRY
2016 AEHS Statistics Sediment Forensic Presentation CHERRY
 
Nanoparticles
NanoparticlesNanoparticles
Nanoparticles
 
UNIT 1 - PREFORMULATION.pptx
UNIT 1 -  PREFORMULATION.pptxUNIT 1 -  PREFORMULATION.pptx
UNIT 1 - PREFORMULATION.pptx
 
Preformulation testing of solid dosage forms
Preformulation testing of solid dosage formsPreformulation testing of solid dosage forms
Preformulation testing of solid dosage forms
 
Nanobiotechnology role in nanomedicine field
Nanobiotechnology role in nanomedicine fieldNanobiotechnology role in nanomedicine field
Nanobiotechnology role in nanomedicine field
 
BRIN research poster
BRIN research posterBRIN research poster
BRIN research poster
 
Session 1 role and importance of dsp in biotechnology
Session 1 role and importance of dsp in biotechnologySession 1 role and importance of dsp in biotechnology
Session 1 role and importance of dsp in biotechnology
 
Drug Discovery subject (clinical research)
Drug Discovery subject (clinical research)Drug Discovery subject (clinical research)
Drug Discovery subject (clinical research)
 

Más de Bhaswat Chakraborty

Más de Bhaswat Chakraborty (20)

Root cause Analysis (RCA) & Corrective and Preventive action (CAPA) in MRCT d...
Root cause Analysis (RCA) & Corrective and Preventive action (CAPA) in MRCT d...Root cause Analysis (RCA) & Corrective and Preventive action (CAPA) in MRCT d...
Root cause Analysis (RCA) & Corrective and Preventive action (CAPA) in MRCT d...
 
Statistical outliers in BE Studies DIA 12 april 2019
Statistical outliers in BE Studies DIA 12 april 2019Statistical outliers in BE Studies DIA 12 april 2019
Statistical outliers in BE Studies DIA 12 april 2019
 
Respiratory studies right approach in designs dia 11 april 2019 r
Respiratory studies right approach  in designs dia 11 april 2019 rRespiratory studies right approach  in designs dia 11 april 2019 r
Respiratory studies right approach in designs dia 11 april 2019 r
 
Simplifying study designs and statistical models for new dose & dosage forms ...
Simplifying study designs and statistical models for new dose & dosage forms ...Simplifying study designs and statistical models for new dose & dosage forms ...
Simplifying study designs and statistical models for new dose & dosage forms ...
 
Equivalence approches for complex generics DIA 11 april 2019
Equivalence approches for complex generics DIA 11 april 2019 Equivalence approches for complex generics DIA 11 april 2019
Equivalence approches for complex generics DIA 11 april 2019
 
Clinical Trial Requirements Medical Devices 27 dec2018
Clinical Trial Requirements Medical Devices 27 dec2018Clinical Trial Requirements Medical Devices 27 dec2018
Clinical Trial Requirements Medical Devices 27 dec2018
 
Writing scientific papers FINALDec 2018
Writing scientific papers FINALDec 2018Writing scientific papers FINALDec 2018
Writing scientific papers FINALDec 2018
 
Multidisc review of NDAs and BLAs nipicon 2018 Dr. Chakraborty
Multidisc review of NDAs and BLAs nipicon 2018 Dr. ChakrabortyMultidisc review of NDAs and BLAs nipicon 2018 Dr. Chakraborty
Multidisc review of NDAs and BLAs nipicon 2018 Dr. Chakraborty
 
Teaching by stories, anecdotes and historical facts sept 25 2018
Teaching by stories, anecdotes and historical facts sept 25 2018Teaching by stories, anecdotes and historical facts sept 25 2018
Teaching by stories, anecdotes and historical facts sept 25 2018
 
Orientation and Adaptation for Post-Graduate Pharmacy Programs
Orientation and Adaptation for Post-Graduate Pharmacy ProgramsOrientation and Adaptation for Post-Graduate Pharmacy Programs
Orientation and Adaptation for Post-Graduate Pharmacy Programs
 
Plagiarism and Techniques to Avoid Plagiarism
Plagiarism and Techniques to Avoid PlagiarismPlagiarism and Techniques to Avoid Plagiarism
Plagiarism and Techniques to Avoid Plagiarism
 
Best Practices to Risk Based Data Integrity at Data Integrity Conference, Lon...
Best Practices to Risk Based Data Integrity at Data Integrity Conference, Lon...Best Practices to Risk Based Data Integrity at Data Integrity Conference, Lon...
Best Practices to Risk Based Data Integrity at Data Integrity Conference, Lon...
 
Ethics in Pharmacy
Ethics in Pharmacy Ethics in Pharmacy
Ethics in Pharmacy
 
Pharmacists in Drug Discovery & Development
Pharmacists in Drug Discovery & Development Pharmacists in Drug Discovery & Development
Pharmacists in Drug Discovery & Development
 
Clinical Development of Biosimilars
Clinical Development of Biosimilars Clinical Development of Biosimilars
Clinical Development of Biosimilars
 
Challenges in Phase III Cancer Clinical Trials
Challenges in Phase III Cancer Clinical Trials Challenges in Phase III Cancer Clinical Trials
Challenges in Phase III Cancer Clinical Trials
 
Bioequivalence of Highly Variable Drug Products
Bioequivalence of Highly Variable Drug ProductsBioequivalence of Highly Variable Drug Products
Bioequivalence of Highly Variable Drug Products
 
Bioequivalence of Highly Variable Drug Products
Bioequivalence of Highly Variable Drug ProductsBioequivalence of Highly Variable Drug Products
Bioequivalence of Highly Variable Drug Products
 
Protein binding of drugs and screening of drugs by physicochemical properties
Protein binding of drugs  and screening of drugs by physicochemical propertiesProtein binding of drugs  and screening of drugs by physicochemical properties
Protein binding of drugs and screening of drugs by physicochemical properties
 
Developing Protocols & Procedures for CT Data Integrity
Developing Protocols & Procedures for CT Data Integrity Developing Protocols & Procedures for CT Data Integrity
Developing Protocols & Procedures for CT Data Integrity
 

Fingerprinting of herbal drugs using advanced bioanalytical techniques

  • 1. Fingerprinting of Herbal Drugs using Advanced Bioanalytical Techniques Dr. Bhaswat S. Chakraborty 10/12/12 1
  • 3. Herbal Drugs as Traditional Medicine “…the medicine that refers to health practices, approaches, knowledge and beliefs incorporating plant, animal and mineral based medicines, spiritual therapies, manual techniques and exercises, applied singularly or in combination to treat, diagnose and prevent illnesses or maintain well-being …” WHO 10/12/12 3
  • 4. Some Indian Medicinal Plants 10/12/12 4
  • 5. Use of Traditional Medicine • Worldwide 40-70% people use traditional medicine (of herbal, animal or mineral origin) – Exclusively, alternately or terminally • The quality of herbal medicines is often poor – Production of herbals is not controlled or regulated • Herbal medicines usually contain a range of pharmacologically active compounds – Often not known which of these constituents produces the therapeutic effect. – Testing for efficacy is more complex than with synthetic drugs • Complex safety issues – Toxicity of natural herbal constituents – Presence of contaminants or adulterants – Herb-herb or herb-prescription drug interactions 10/12/12 5
  • 6. Renewed Interest in Herbal Medicine • The effectiveness of plant medicines. • The preference of consumers for natural therapies, a greater interest in alternative medicines and a commonly held erroneous belief that herbal products are superior to manufactured products. • A dissatisfaction with the results from synthetic drugs and the belief that herbal medicines might be effective in the treatment of certain diseases where conventional therapies and medicines have proven to be inadequate. • The high cost and side effects of most modern drugs. • Improvements in the quality, efficacy, and safety of herbal medicines with the development of science and technology. • Patients’ belief that their physicians have not properly identified the problem; hence they feel that herbal remedies are another option. • A movement towards self-medication 10/12/12 6
  • 7. But the Problem is • Herbal drugs are usually mixtures of many constituents. • The active principle(s) is (are), in most cases unknown. • Selective analytical methods or reference compounds may not be available commercially. • Plant materials are chemically and naturally variable. • The same species varies in various drug contents depending on locality, cultivation process, etc. • The source and quality of the raw material are variable. • The methods of harvesting, drying, storage, transportation, and processing (for example, mode of extraction and polarity of the extracting solvent, instability of constituents, etc.) have an effect. 10/12/12 7
  • 8. QC of Herbal Drugs • Identity • Purity • Content or assay – very challenging for herbal drugs • Parameters for Quality Control of Herbal Drugs – Microscopy – Foreign matter determination – Determination of ash – Determination of heavy metals – Determination of Microbial Contaminants and Aflatoxins – Determination of Pesticide Residues – Determination of Radioactive Contamination – Analytical method and its validation 10/12/12 8
  • 9. Why QC Herbal Drugs? • Accurate identity and specifications • Content uniformity • Reduced batch to batch variability • Efficacy related to quality • Safety – Some sub-species can be very toxic • Raw drug and dosage form stability • Control of shelf life decreasing contaminations 10/12/12 9
  • 10. Sample Preparation for Chromatographic Fingerprinting • Follows the same priciples as those for any HPLC (or other chromatographic) analysis • Herbs may require very specific additional steps prior to chromatographic analysis – Grinding and pulverizing – Extraction • Organic solvent • Organic solvent free • Super-critical fluid • Co-solvent super-critical – Hydro-distillation of essential oils 10/12/12 10
  • 11. Instead of chemical solvent, compressed CO2 is used. It is a fine extracting solvent and doesn’t contaminate the herb, environment or our body. 10/12/12 11
  • 13. MS vs. MS/MS Mass HPLC Inlet Ionize Detect Analyze MS Separation Identification Mass Mass Inlet Ionize Fragment Detect Analyze Analyze MS1 Collision MS2 Cell MS/MS 10/12/12 13
  • 14. Chromatographic Fingerprinting of Herbs • These are chromatograms representing characteristics of the herbs – Identity, consistency and authenticity of samples • Hyphenated techniques (GC/MS, LC/MS and CE/MS) show greatly improved performances – retention time shift, selectivity, chromatographic separation abilities and measurement precision • Chromatographic fingerprinting is a highly accurate, meaningful quality control method of herbal medicines • Since it is usually difficult to distinguish herbal drugs by different manufactures visually, principal components analysis (PCA) is used. 10/12/12 14
  • 15. Curcumin + 1 0 1 m fr m a p 1( 1 4 9 P S IV ( 1_ U C M ) o Q .w ( ub S r y, C n o e Q : .0 7 in o S mle 0 0 0 _ O IT EQ ) C R U IN f 1 iff T r o pa ) e tr id d Mx 2 e c s a . .3 7 p . 23 2 .1 2 e .3 7 2 e .2 7 2 e .1 7 2 e .0 7 1 e .9 7 1 e .8 7 1 e .7 7 1 e .6 7 1 e .5 7 22 1 .0 1 e .4 7 Intensity, cps 1 e .3 7 27 1 .0 1 e .2 7 1 e .1 7 1 e .0 7 31 9 .4 29 7 .2 9 e .0 6 24 4 .9 8 e .0 6 26 9 .2 7 e .0 6 44 6 .5 39 6 .1 6 e .0 6 26 5 .3 34 3 .6 22 3 .4 22 0 .1 5 e .0 6 29 4 .2 21 6 .1 35 0 .2 23 1 .9 26 30 6 .2 0 .5 32 5 .3 48 43 0 .5 1 .4 4 e .0 6 3 4 1 .0 1 .33 9 42 9 .6 2 .1 2 0 2 5 21 3 .1 3 .1 25 21 7 .0 9 .1 38 5 .3 38 8 .4 41 48 1 .4 2 .5 45 6 .4 3 e .0 6 21 5 .4 33 6 .2 45 5 .3 33 0 .2 34 4 .3 40 0 .6 22 7 .3 36 2 .8 37 7 .2 42 3 .4 48 44 5 .4 7 .6 55 53 2 .0 3 .0 5 0 5 .8 2 e 27 25 28 .0 6 0 .1 1 .3 3 .9 23 6 .2 35 39 6 .2 7 .1 57 0 .3 58 7 .9 32 4 .4 45 2 .3 56 51 1 .9 4 .0 55 6 .3 34 7 .4 47 4 .3 40 7 .5 4 8 54 4 .9 52 9 .7 1 e .0 6 7 .9 43 2 .4 57 8 .2 20 0 20 2 20 4 20 6 20 8 30 0 30 2 30 4 30 6 30 8 40 0 40 2 40 4 40 6 40 8 50 0 50 2 50 4 50 6 50 8 60 0 m ,a u /z m 10/12/12 15
  • 16. Total Ion Current of Parent Ion Parent Ion of Curcumin
  • 17. HPLC Fingerprint of Ashwagandha 10/12/12 Dr. Quazi et al (downloaded), CSIR 17
  • 18. Glycowithanolides and Withanolides from Ashwagandha 10/12/12 Dr. Quazi et al (downloaded), CSIR 18
  • 19. LC-MS Fingerprint of Ashwagandha 10/12/12 Dr. Quazi et al (downloaded), CSIR 19
  • 20. Fingerprint of Formulations 10/12/12 20 Dr. Quazi et al (downloaded), CSIR
  • 21. Total Ion Chromatogram of Ginseng Sample 10/12/12 21
  • 22. 10/12/12 Chromatograms of Different Batches of Ginseng in Shenmai injection 22
  • 23. Similarity of Fingerprints • Equivalence of herbal drugs of different sources – “Phytoequivalence” – Very good, reproducible and accurate chromatograms are needed • For good comparison, correction of retention time shifts of the component drugs is necessary • So many components from so many sources – Visual comparison is extremely difficult – May even be misleading • Chemometric techniques,e.g., Principal Component Analysis (PCA) are used to confirm similarity or dis- similarity 10/12/12 23
  • 24. Phytoequivalence TIC of essential oils of Cortex cinnamomi from four different sources 10/12/12 Liang et al (2004), J Chromat B, 812, 53-70 24
  • 25. Correction for RT Shift Chromatograms of Ginko biloba samples by two different HPLC instruments 10/12/12 Liang et al (2004), J Chromat B, 812, 53-70 25
  • 26. Principal Component Analysis HPLC UV of G. biloba extracts from 17 different sources 10/12/12 Liang et al (2004), J Chromat B, 812, 53-70 26
  • 27. Principal Component Analysis HPLC UV of G. biloba extracts from 17 different sources Different fingerprint from those below 10/12/12 Liang et al (2004), J Chromat B, 812, 53-70 27
  • 28. Principal Component Analysis HPLC UV of G. biloba extracts from 17 different sources 10/12/12 Liang et al (2004), J Chromat B, 812, 53-70 28
  • 29. On-Line Chemometric Comparison HPLC-MS TIC of Schisandra extracts by 6 different methods Liang et al (2004), 10/12/12 J Chromat B, 812, 53-70 29
  • 30. DNA Microarray of Herbal Drugs 10/12/12 Wang M et al (2005), Phytotherap Res 19, 173-182 30

Notas del editor

  1. Tandem MS 10/12/12 Dr. Edward Randell In the upper part of this slide, we can see a block diagram of a mass spectrometer. We have the sample inlet, the ion source, the mass analyser or separator, and the detection system. What we have in a tandem mass spectrometer is.... well, two mass spectrometers in tandem. We have the inlet system and the ion source and the first mass analyser, but what we have then is a region in which we can controllably break the ions down. That is, the ionic species passing out of the first mass spectrometer pass into this collision region and break down by colliding with a neutral target gas, typically argon. The fragmentation that occurs in the collision cell is highly dependent on the amount of energy we deposit into the molecules (by controlling the speed of the ions as they enter the collision cell, and the number of collisions they undergo with the target gas) and the chemical structure of the molecules. The fragments that are generated in the collision cell then pass through into the second mass analyser where they are separated according to their mass to charge ratios again, and we can record the MS/MS spectrum on the detector. The specificity of this experiment comes from the fact that all the fragment ions that are generated in the collision cell, and recorded in the spectrum, are derived from the mass that is passed through from the first mass analyser. We know, therefore, that all the product, or daughter ions, are all derived from a single precursor, or parent. If we are analysing a mixture of compounds, we are effectively separating them out according to their masses before we generate their mass spectra. This is not an easy concept to grasp straight off, so let's compare tandem mass spectrometry to GC-MS........ (which may or may not be in use in the audience's laboratory, but they are likely to have heard of it).